The arrival of the Retatru vial represents a potential advance in the approach to weight control . This novel medication combines dual mechanisms – stimulation of the GLP-1 receptor and reduction of the DPP-4 factor – providing a distinctive method for managing obesity . Early clinical data indicate encouraging effectiveness in facilitating sig